Ambrisentan: A guide to its use in pulmonary arterial hypertension classified as WHO functional class II or III

被引：0

作者：

Behr J. ^{[1
]}

Lyseng-Williamson K.A. ^{[2
]}

机构：

[1] Division of Pulmonary Diseases, Department of Internal Medicine i, University of Munich, Munich

[2] Adis, A Wolters Kluwer Business, Auckland

来源：

Drugs & Therapy Perspectives | 2011年 / 27卷 / 1期

关键词：

Ambrisentan; therapeutic use; Endothelin-receptor-antagonists; Pulmonary-hypertension; treatment; Treatment-algorithms;

D O I：

10.2165/11205380-000000000-00000

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用

页码：1 / 8

页数：7

共 50 条

[1] Ambrisentan ± tadalafil in WHO functional class II/III pulmonary arterial hypertension: a guide to its use in the EU
Lyseng-Williamson K.A.
Behr J.
Drugs & Therapy Perspectives, 2018, 34 (7) : 289 - 299
[2] Correction to: Ambrisentan ± tadalafil in WHO functional class II/III pulmonary arterial hypertension: a guide to its use in the EU
Katherine A. Lyseng-Williamson
Jürgen Behr
Drugs & Therapy Perspectives, 2019, 35 : 47 - 47
[3] Correction to: Ambrisentan ± tadalafil in WHO functional class II/III pulmonary arterial hypertension: a guide to its use in the EU
Katherine A. Lyseng-Williamson
Jürgen Behr
Drugs & Therapy Perspectives, 2018, 34 (10) : 496 - 496
[4] Ambrisentan +/- tadalafil in WHO functional class II/III pulmonary arterial hypertension: a guide to its use in the EU (vol 34 pg 289, 2018)
Lyseng-Williamson, Katherine A.
Behr, Juergen
DRUGS & THERAPY PERSPECTIVES, 2018, 34 (10) : 496 - 496
[5] Ambrisentan ± tadalafil in WHO functional class II/III pulmonary arterial hypertension: a guide to its use in the EU (vol 34, pg 289, 2018)
Lyseng-Williamson, Katherine A.
Behr, Jurgen
DRUGS & THERAPY PERSPECTIVES, 2019, 35 (01) : 47 - 47
[6] Macitentan: a guide to its use in the treatment of pulmonary arterial hypertension in adults of WHO functional class II or III in the EU
Lyseng-Williamson K.A.
Yang L.P.H.
Dhillon S.
Drugs & Therapy Perspectives, 2015, 31 (3) : 83 - 88
[7] Ambrisentan: a guide to its use in pulmonary arterial hypertension
Drugs & Therapy Perspectives, 2009, 25 (7) : 1 - 5
[8] Ambrisentan in pulmonary arterial hypertension: a guide to its use in the EU
Behr J.
Lyseng-Williamson K.A.
Drugs & Therapy Perspectives, 2016, 32 (2) : 50 - 59
[9] Ambrisentan: A guide to its use in pulmonary arterial hypertension in the EU
Behr J.
Lyseng-Williamson K.A.
Drugs & Therapy Perspectives, 2014, 30 (7) : 231 - 240
[10] Erratum to: Ambrisentan: a guide to its use in pulmonary arterial hypertension in the EU
Jürgen Behr
Katherine A. Lyseng-Williamson
Drugs & Therapy Perspectives, 2014, 30 (8) : 302 - 302

← 1 2 3 4 5 →